rs4252583
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000526180.6(CRYAB):c.-224-150C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00802 in 275,266 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.012 ( 34 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 4 hom. )
Consequence
CRYAB
ENST00000526180.6 intron
ENST00000526180.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.02
Publications
1 publications found
Genes affected
CRYAB (HGNC:2389): (crystallin alpha B) Mammalian lens crystallins are divided into alpha, beta, and gamma families. Alpha crystallins are composed of two gene products: alpha-A and alpha-B, for acidic and basic, respectively. Alpha crystallins can be induced by heat shock and are members of the small heat shock protein (HSP20) family. They act as molecular chaperones although they do not renature proteins and release them in the fashion of a true chaperone; instead they hold them in large soluble aggregates. These heterogeneous aggregates consist of 30-40 subunits; the alpha-A and alpha-B subunits have a 3:1 ratio, respectively. Two additional functions of alpha crystallins are an autokinase activity and participation in the intracellular architecture. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Alpha-A and alpha-B gene products are differentially expressed; alpha-A is preferentially restricted to the lens and alpha-B is expressed widely in many tissues and organs. Elevated expression of alpha-B crystallin occurs in many neurological diseases; a missense mutation cosegregated in a family with a desmin-related myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2019]
CRYAB Gene-Disease associations (from GenCC):
- myofibrillar myopathy 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
- cataract 16 multiple typesInheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
- fatal infantile hypertonic myofibrillar myopathyInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet
- early-onset lamellar cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset nuclear cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset posterior polar cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathy 1IIInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 11-111912098-G-A is Benign according to our data. Variant chr11-111912098-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1207966.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0123 (1869/152238) while in subpopulation AFR AF = 0.0396 (1643/41510). AF 95% confidence interval is 0.038. There are 34 homozygotes in GnomAd4. There are 861 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 34 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CRYAB | NM_001289807.1 | c.-198-176C>T | intron_variant | Intron 1 of 3 | NP_001276736.1 | |||
| CRYAB | NM_001368245.1 | c.-198-176C>T | intron_variant | Intron 1 of 3 | NP_001355174.1 | |||
| CRYAB | NM_001885.3 | c.-198-176C>T | intron_variant | Intron 1 of 3 | NP_001876.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CRYAB | ENST00000526180.6 | c.-224-150C>T | intron_variant | Intron 1 of 3 | 1 | ENSP00000436051.1 | ||||
| CRYAB | ENST00000527899.6 | c.-198-176C>T | intron_variant | Intron 1 of 3 | 2 | ENSP00000436089.2 | ||||
| CRYAB | ENST00000527950.5 | c.-198-176C>T | intron_variant | Intron 1 of 3 | 5 | ENSP00000437149.1 |
Frequencies
GnomAD3 genomes AF: 0.0123 AC: 1867AN: 152120Hom.: 34 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1867
AN:
152120
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00276 AC: 339AN: 123028Hom.: 4 Cov.: 0 AF XY: 0.00231 AC XY: 149AN XY: 64590 show subpopulations
GnomAD4 exome
AF:
AC:
339
AN:
123028
Hom.:
Cov.:
0
AF XY:
AC XY:
149
AN XY:
64590
show subpopulations
African (AFR)
AF:
AC:
184
AN:
4856
American (AMR)
AF:
AC:
42
AN:
6316
Ashkenazi Jewish (ASJ)
AF:
AC:
7
AN:
3370
East Asian (EAS)
AF:
AC:
2
AN:
7016
South Asian (SAS)
AF:
AC:
0
AN:
16362
European-Finnish (FIN)
AF:
AC:
1
AN:
4562
Middle Eastern (MID)
AF:
AC:
6
AN:
498
European-Non Finnish (NFE)
AF:
AC:
69
AN:
73492
Other (OTH)
AF:
AC:
28
AN:
6556
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0123 AC: 1869AN: 152238Hom.: 34 Cov.: 32 AF XY: 0.0116 AC XY: 861AN XY: 74434 show subpopulations
GnomAD4 genome
AF:
AC:
1869
AN:
152238
Hom.:
Cov.:
32
AF XY:
AC XY:
861
AN XY:
74434
show subpopulations
African (AFR)
AF:
AC:
1643
AN:
41510
American (AMR)
AF:
AC:
141
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
2
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
51
AN:
68020
Other (OTH)
AF:
AC:
20
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
91
181
272
362
453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 26, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.